Skip to content

A prospective QOL survey of carbon ion radiotherapy in 12 fractions for prostate cancer

A prospective QOL survey of carbon ion radiotherapy in 12 fractions for prostate cancer - A prospective QOL survey of carbon ion radiotherapy in 12 fractions for prostate cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037680
Enrollment
300
Registered
2019-08-14
Start date
2016-10-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Sponsors

Gunma University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Prostate cancer (adenocarcinoma) that has been confirmed by biopsy. 2) T1c-T3N0M0 (2009, UICC 7th edition). 3) The age at the time of registration is 20 to 80 years old. 4) Performance Status (ECOG) is 0-2. 5) The name and condition of the disease have been announced to the person. 6) The person must be able to agree.

Exclusion criteria

Exclusion criteria: 1) History of radiation therapy in the pelvis. 2) Active double cancer (simultaneous double cancer and metachronous double cancer with a disease-free period of 5 years or less). However, lesions equivalent to intraepithelial cancer or intramucosal cancer that are judged to be cured by local treatment are not included in active double cancer. 3) Patients who have undergone prior endocrine therapy and deviate from the endocrine therapy combination rule according to the risk. 4) castration resistant at the time of enrollment. 5) Patients who refuse to use endocrine therapy according to risk. 6) Cases with serious complications 7) Medical doctors determine that the doctor in charge is inappropriate due to medical, psychological or other factors.

Design outcomes

Primary

MeasureTime frame
Expanded Prostate Cancer Index Composite (EPIC) Short Form with 8 questions (SF-8) EuroQol 5 Dimension (EQ-5D(5L))

Countries

Japan

Contacts

Public ContactHidemasa Kawamura

Gunma University Hospital Heavy Ion Medical Center

kawa@gunma-u.ac.jp027-220-8378

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026